Safety, Activity, and Pharmacology of Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
November 11, 2019
End Date
August 20, 2020
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
November 11, 2019
End Date
August 20, 2020